Join us as we DISCOVER, ANALYZE and LEARN the current state of the global biomanufacturing industry and the future growth potential and recent developments in Asia. Some of the Key Highlights You Won’t Want to Miss Include USA Smart & Flexible Manufacturing Solutions in Multi-Product Facilities Franz Walz, Executive Director Global Manufacturing, Science and Technology & Network Coordination, BOEHRINGER INGELHEIM EUROPE MAb Manufacturing Facilities for China & Automated Single-Use Processing to Bring Control & Flexibility to Manufacturing Pauline Nicholson, Global Product Manager, Allegro Single-Use Systems, PALL Niels Guldager, Senior Technology Partner, NNE PHRAMAPLAN KOREA: How to Bring Global Biopharmaceutical Capability through its Fully-Integrated Production Facilities? Jeremy Caudill, Global VP Business Development, SAMSUNG BIOLOGICS SINGAPORE What do Investors Look for When Investing in Biologics Manufacturing? Steven Lee, Global Head of Biologics Tech Operations & Managing Director, DR. REDDY'S LABORATORIES INDIA Developing a Multiproduct Facility for Biosimilars & Engineering & Biomanufacturing of Enzymes for Different Applications Arvind Mishra, Global Head of Quality & Regulatory & Head of Strategic Business Unit, Biologicals, CADILLA PHARMACEUTICALS Ravindra Wagh, Vice President, ZYDUS BIOLOGICS Rajeev Soni, Senior Manager, R&D, NOVOZYMES HONGKONG What are the Experiences & What is the Future for the Investors in the Biomanufacturing Space? Ramesh Rajentheran, Head of Asian Healthcare Investment Banking, BARCLAYS Jason Mann, Managing Director, FENEX CAPITAL MANAGEMENT INDONESIA Improving Quality Control & Maintenance of Global Biological Product Distribution Galatia Chandra, Head of Sales & System, Global Operation, KALBE INTERNATIONAL PTE LTD http://www.biomanufacturing-asia.com

1. Produced by: Associations:
International Marketing
Partner:
www.biomanufacturing-asia.com
Increasing Production, Enhancing Quality & Optimizing Operations
Part of
PRODUCTION
BIOPHARMA
DEVELOPMENT &
WEEK
20 — 23 May 2014
Grand Hyatt Shanghai, China
IBC LIFE
SCIENCES
PLUS:
• WUXI APPTEC • SANOFI • NOVARTIS
• TAKEDA PHARMACEUTICAL • BAXTER
& many more!
BIOBIO
4TH ANNUAL
Jingrong Li
Executive Director, Biologics,
SIMCERE PHARMACEUTICALS, CHINA
Key Conference Themes:
• Regulations, GMP & Standards
• Successful Partnerships, Investment
& Financing
• Effective Planning, Facility Design &
Development
• Improving Operations & Supply Chain
Management
• Cost Effective Single-Use Systems &
Technology Transfer
Steven Lee
Global Head of Biologics Tech Operations &
Managing Director,
DR. REDDY’S LABORATORIES, SINGAPORE
THE 2014 NEW EXPERT FACULTY INCLUDES:
Ting Xu
Founder & CEO,
ALPHAMAB, CHINA Racho Jordanov
President & CEO,
JHL BIOTECH, TAIWAN
PRE-CONFERENCE WORKSHOP: 20 MAY 2014
Biomanufacturing Technologies & Facility Design
POST-CONFERENCE WORKSHOP: 23 MAY 2014
Meeting International Quality & Regulatory
Requirements in Biomanufacturing
Media Partners:
Jeremy Caudill
Global VP Business Development,
SAMSUNG BIOLOGICS, KOREA
Darren Ji
Global Head, Asia Emerging Markets Partnering,
F. HOFFMANN-LA ROCHE, CHINA
Life
Sciences

2. REGISTERTODAY! +65 6508 2401 / +86 21 2326 3680 register@ibcasia.com.sg www.biomanufacturing-asia.com
12.50 Networking Lunch & VIP Tables
VIP Table 1: Jian Dong, DeputyGeneralManager, SHANGHAI UNITED
CELL BIOTECHNOLOGY, CHINA
VIP Table 2: Jeremy Caudill, Global VP Business Development,
SAMSUNG BIOLOGICS, KOREA
If you would like to be seated on a table with the above guests in an
exclusive lunch setting, please register your interest with
gladys.landicho@ibcasia.com.sg. Limited seats are available!
2.30 Examining the Impact of the US H.R. 3204 Drug Quality & Security
Act in the Biomanufacturing Industry
• What are the substandard or counterfeit medicines & where are
counterfeit medicines found?
• To what extent could substandard medicine be considered as
counterfeit & what should be done to ensure the safety, efficacy &
quality of medicines?
• Dealing with corruption & conflict of interest & what consumers
should do?
• How to boost security in the biopharmaceutical supply chain?
• Understanding the effects of traceability requirement in the supply
chain partners & pharmacies
Masih Sabet, Associate Director, Quality Assurance, UCB, CHINA
PARTNERSHIPS, INVESTMENT & FINANCING
3.00 Critical Success Factors for Choosing the Right Biomanufacturing
Outsourcing Partner
• What are the essential partner attributes to look for when selecting
a partner?
• Identifying the best technology capacity
• Determining the partner’s expression platform
• Maximizing the outsourcing opportunities in Asia
Kang Li, Head of Biologics, BEIGENE, CHINA
3.30 Afternoon Networking & Refreshment Break
4.00 What do Investors Look for When Investing in Biologics
Manufacturing?
• Examining business models & growth strategies
• Attracting foreign investors
• Ensuring financial security in the biomanufacturing business
• Selecting & managing partners
~ Prototyping
~ Negotiating
StevenLee, GlobalHeadofBiologicsTechOperations&ManagingDirector,
DR. REDDY’S LABORATORIES, SINGAPORE
4.30 Venture Capital & Private Equity in the Biomanufacturing Space –
What are the Experiences & What is the Future for Investors?
• Understanding the growing pipeline of biologics portfolio
• What are the current trends in the biomanufacturing industry in
Asia?
• What are the investment opportunities for entering the
biomanufacturing market in China as compared to other countries
in Asia?
• What are the risks involved in investing in the biomanufacturing
industry?
Panelists:
Ramesh Rajentheran, Head of Asian Healthcare Investment Banking,
BARCLAYS, HONG KONG
Nisa Leung, Managing Partner, QIMING VENTURE PARTNERS, CHINA
Jason Mann, Managing Director, FENEX CAPITAL MANAGEMENT,
HONG KONG
5:30 Chairperson’s Summary of Day One
6.00 Speed Networking & Networking Cocktail
VIP 1: Atul Deshpande, Associate Director, Unit Strategy Officer,
Asia Pacific, SANOFI, CHINA
VIP 2: Sune Duus Svenningsen, Head of Operations, Asia Pacific,
NOVARTIS, CHINA
Exclusive to Registered Participants Only: Limited Spots Available!
Participants have the chance to spend two minutes getting to know
the below key experts in the Biopharma Industry! Secure your place
today with gladys.landicho@ibcasia.com.sg
7.00 End of Conference Day One
DAY ONE 21 May 2014 | Wednesday
08:00 Registration Opens & Morning Coffee
08:50 Welcome Address from IBC Asia & Ice Breaker
Exchange Business Cards & Get To Know Industry Peers
09:00 Chairperson’s Opening Remarks
BIOPHARMA VISIONARY KEYNOTE SESSIONS
09:05 Global Biopharma Outlook
• Trends in the global biopharma industry
• Priorities of investment in China & opportunities for growth
• Challenges & opportunities in the Asian region
• The role of Biosimilars in the region’s biopharma industry
• Key criteria to further the development of the sector in China and
Asia
Moderator:
Scott Liu, CEO, HENLIUS PHARMACUETICALS, CHINA
Panelists:
Youling Wu, CEO, ZHEJIANG TERUISI, CHINA
Jianguo Yang, Principal Scientist, SANOFI GENZYME, USA
Jeremy Caudill, Global VP Business Development, SAMSUNG
BIOLOGICS, KOREA
Abdullah Baaj, CEO, BOSTON ONCOLOGY, USA
Sameer Agarwal, Senior Vice President, Business Center Strategic
Marketing, Business Unit Generic Drugs & Standard Solutions, FRESENIUS
KABI DEUTSCHLAND GMBH, GERMANY
09:50 Biopharma Regulatory Updates & Development
• Clinical approvals for biopharmaceuticals
• Regulatory differences between the FDA/EMA/ICH & local agencies
in China & other emerging markets such as India & SEA
• How to demonstrate process consistency & what is required?
• Accelerating IND applications
• Updates on Biosimilars guidelines in key Asian markets
Panelists:
Victoria Elegant, Vice President, Medical & Regulatory Affairs, BAXTER,
CHINA
Andrea Laslop, Head of Scientific Office, AUSTRIAN AGENCY FOR
HEALTH AND FOOD SAFETY (AGES) PHARMMED, AUSTRIA & Austrian
Member, Committee for Human Medicinal Products (CHMP), EUROPEAN
MEDICINES AGENCY (EMA), AUSTRIA
Dr.ArvindMishra,GlobalHeadofQuality&Regulatory&HeadofStrategic
Business Unit, Biologicals, CADILLA PHARMACEUTICALS, INDIA
BIOPHARMA TECHNOLOGY SHOWCASE
10:30 Cutting Edge Solutions & Innovation in Biopharma
If you have leading edge technology & solutions & would like to
showcase your innovation in front of biopharma industry stakeholders,
please contact Yvonne Leong: Yvonne.leong@ibcasia.com.sg
11:00 Morning Networking & Refreshment Break
11.45 Chairperson’s Opening Remarks
Jeremy Caudill, Global VP Business Development, SAMSUNG
BIOLOGICS, KOREA
QUALITY & GMP STANDARDS
11.50 Bridging the Quality Differences of China GMP Standards vs. Europe
& the US
• Examining the quality assurance procedures
• Analyzing the facility requirements
• Assessing differences in standards
• Determining the effects vs. quality of products outsourced from
China
JingrongLi, ExecutiveDirector,Biologics, SIMCEREPHARMACEUTICALS,
CHINA
12.10 Developing a Multiproduct Facility for Biosimilars According to
GMP Standards
• Risk management techniques during design
• Does the multiproduct facility affect the product?
• Cleaning validation study for multi-product equipment
• Identifying the best multiproduct facility management strategies
Shaligram Rane, Vice President, Quality, INTAS PHARMACEUTICALS
LTD, INDIA
12.30 The US FDA Quality Inspection Standards for Biological Products
Manufactured in China
• Examining the facility, management & control system
• Ensuring the quality of the biological products manufactured in
China are up to US FDA standards
• Comparing how the US FDA & CFDA define a state of control for:
~ Plant layout
~ Smooth work flows
~ Efficient documentation systems
~ Well controlled processes
• What are the strategies on how to prepare for an inspection?
• How to deal with the inspector? What to communicate & how to
communicate effectively with an inspector?
Shaoyu Chen, Managing Director, China Food & Drug Practice,
COVINGTON & BURLING LLP, CHINA & Former, Assistant Chief Counsel,
FOOD AND DRUG ADMINISTRATION, USA
REGULATORY
LEADERSPANEL
PANELDISCUSSION

3. PANELDISCUSSION
12.00 Networking Luncheon & VIP Lunch Tables
VIP Table 1: Sune Duus Svenningsen, Head of Operations,
Asia Pacific, NOVARTIS, CHINA
VIP Table 2: Darren Ji, Global Head, Asia & Emerging Markets
Partnering, F. HOFFMANN-LA ROCHE, CHINA
If you would like to be seated on a table with the above guests in an
exclusive lunch setting, please register your interest with
gladys.landicho@ibcasia.com.sg. Limited seats are available!
BIOMANUFACTURING TECHNOLOGIES & TECHNOLOGY TRANSFER
2.00 Developing a Robust Commercial Process for Technology Transfer:
Ensuring Product Comparability to Avoid Rejection
• Comparative protocols to demonstrate the same quality of products
produced
• What could be the impact of technology transfer?
~ Manpower
~ Cost
~ Quality
• To what extent can the R&D process be copied?
Rajeev Soni, Associate Vice President, Research & Development, BIOCON,
INDIA
3.00 Afternoon Networking & Refreshment Break
3.30 To What Extent Could Disposable Technologies Be a Commercial
Manufacturing Technology in China?
• What are the requirements from the government?
• Examining the validation of lethable and extractable. Is it safe to
do?
• Examining the growth potential & opportunity for disposable
technologies
Panelists:
Lei Sun, Vice President, Technology & Manufacture, AUTEKBIO, CHINA
Jason Li, Senior Director, Downstream Processing, GENOR BIOPHARMA,
CHINA
Racho Jordanov, President & CEO, JHL BIOTECH, TAIWAN
Jimmy Li, Executive Director of Biologics & Bioprocesses, WUXI APPTEC,
CHINA
ROUND TABLE DISCUSSIONS
4:30 Round Table Discussions
Financing & Investment Opportunities in the Biomanufacturing
Industry
Jason Mann, Managing Director, FENEX CAPITAL MANAGEMENT,
HONGKONG
Examining Disposable Solutions
Jason Li, Senior Director, Downstream Processing, GENOR BIOPHARMA,
CHINA
Optimizing Operations in Biomanufacturing
Sune Duus Svenningsen, Head of Operations, Asia Pacific, NOVARTIS,
CHINA
Limited Seats Are Available! Secure your place with
gladys.landicho@ibcasia.com.sg
5:30 Chairperson’s Summary of the Day & End of Conference
REGISTERTODAY! +65 6508 2401 / +86 21 2326 3680 register@ibcasia.com.sg www.biomanufacturing-asia.com
DAY TWO 22 May 2014 | Thursday
08.55 Chairperson’s Opening Remarks
JeremyCaudill, GlobalVPBusinessDevelopment, SAMSUNGBIOLOGICS,
KOREA
BIOMANUFACTURING PLANNING, FACILITY DESIGN & DEVELOPMENT
09.00 Setting up A Vaccine Manufacturing Facility in China: What to Do
& What to Expect?
• Overview of the China vaccine market
• Identifying the key success factors to set up a vaccine business in
China
• Understanding the business penetration model in China
• What are the innovative approaches & best practices in vaccine
manufacturing?
Homer He, Vice President, SHANGHAI LEIYUNSHANG WEST
PHARMACEUTICAL & General Manager, SHANGHAI JINGAN
PHARMACEUTICAL, CHINA
9.20 Biomanufactuing Production Capacity Planning, Scale Up &
Development
• Production capacity planning & considerations
• Successful comparability study design between pilot scale &
commercial scale
• Determining the proper commercial scale in biologics
~ Designing & planning procedures
• Reducing animal source materials in biomanufacturing
Yong Ho Ahn, Vice President & Head of Biosimilar & Process Development,
HANHWA BIOLOGICS, KOREA
9.40 Opportunities & Development for Follow-on Complex Biologics
Production
• In depth understanding of complex biologics, Abetacept
• Understanding the development of Abetacept biosimilar
• Analysing the QbD approach during Abatacept development
Ting Xu, CEO & President, ALPHAMAB, CHINA
10:00 Morning Networking & Refreshment Break
OPTIMIZING OPERATIONS & SUPPLY CHAIN MANAGEMENT
10.30 Improving Quality Control & Maintenance of Global Biological
Product Distribution
• Engaging the different distribution channels
• Warehousing & distribution procedures
• Appropriate storage condition
• Engaging third party suppliers
Galatia Chandra, Head of Sales & System, Global Operation,
KALBE INTERNATIONAL PTE LTD, INDONESIA
11.00 Best Practices in Cold Chain Temperature Mapping for
Biopharmaceutical and Pharmaceutical Products
• Analyzing the importance of cold chain temperature mapping in
biomanufacturing
• Understanding complexities of the supply chain
• Is there an overlap between GDP & GMP?
• What are the bulk pharmaceutical shipment systems between
upstream & downstream processing facilities?
Omar Tabanjeh, Associate Director, Head of Quality Assurance, Middle
East, Turkey & Africa, TAKEDA PHARMACEUTICALS, UAE
11.30 Analyzing the Biomanufacturing Supply Chain Challenges &
Potential Solutions
• How regulatory challenges affect launching new products in terms
of patency & GMP issues?
• What are the financial risky challenges that shape the supply chain
strategy in case of unexpected currency change rates?
• How politics influence the Supply Chain Manager’s decisions?
• Contracting & importing biopharmaceuticals
Mina Ghaly, Head of Procurement Office, EVA PHARMA, CHINA

4. Biomanufacturing Technologies & Facility
Design
The purpose of this workshop is to acquaint the participant with
current technology trends in biomanufacturing and key facility design
concepts.
8.30 Registration
8.50 Introduction
9.00 Session 1: Biomanufacturing Landscape in China
• Existing biomanufacturing facilities in China
• Recent additions and on-going plans for new facilities
10.00 Session 2: Facility Size & Scales
• Factors to consider in deciding manufacturing scales
• Large vessel vs multiple smaller vessels?
10.45 Coffee Break
11.15 Session 3: Manufacturing Technologies: Disposable vs.
Stainless Steel
• Pros & cons of disposable & stainless steel facilities
• How should the decision be made – factors to consider?
12.00 Networking Lunch Break
13.30 Session 4: Facility Design – Basic Concepts
• Key concepts for facility design
• Facility design steps & timelines
14.30 Session 5: Facility Design – Process Design Concepts
• How should process design integrate with facility design?
• Process design principles
15.00 Coffee Break
15.30 Session 6: Design of Drug Product (Fill Finish) Facility
• Challenges in drug product facility design
• Examples of a drug product facility
16.15 Session 7: Facility Start-Up & Commissioning
• Key activities/milestones in facility start-up
• Case study: 1st cGMP biologics facility start-up & commissioning
17.15 Closing Remarks & End of Workshop
Meeting International Quality & Regulatory
Requirements in Biomanufacturing
The purpose of this workshop is to acquaint the participant with a
strong understanding of how to improve their regulatory submissions
& quality systems, & how to successfully pass a foreign inspection.
8.30 Registration
8.50 Introduction
9.00 Session 1: Preparation of Clinical Trial Applications (CTA)
• CTA & Investigational New Drug (IND) applications for Europe &
the US
• Guide to the preparation of documents
• Key issues and common pitfalls
10.00 Session 2: Good Record Keeping in Support of Regulatory
Applications
• Understanding the value of development reports
• Key writing skills for clear communication
10.30 Coffee Break
11.00 Session 3: Drug Master Files & Facility Registration
• Types of drug master files in Europe and US
• How to prepare & submit a master file?
• How to register your facility?
12.00 Networking Lunch Break
13.30 Session 4: Quality Systems
• Key Quality Systems for international cGMP
• How to establish & organize your quality program?
14.30 Session 5: Current Quality Issues
• Current topics in Quality Assurance
• Examples & case studies of real problems
15.00 Coffee Break
15.30 Session 6: Preparing for Inspections & Audits
• How to prepare your company for foreign inspections and audits?
• How to work with inspectors & auditors?
• How to reply to observations?
16.30 Session 7: cGMP Facility Design
• Variations in requirements between different regulatory agencies
• Basic principles for facility
• Review of facility examples
17.30 Closing Remarks & End of Workshop
REGISTERTODAY! +65 6508 2401 / +86 21 2326 3680 register@ibcasia.com.sg www.biomanufacturing-asia.com
WORKSHOPS
PRE-CONFERENCE WORKSHOP: 20 MAY 2014 • Tuesday POST-CONFERENCE WORKSHOP: 23 MAY 2014 • FRIDAY
Jincai (Jimmy) Li
Executive Director of Biologics & Bioprocesses,
WUXI APPTEC, CHINA
Scott M. Wheelwright
Co-Founder & Principal Consultant,
COMPLY ASIA CO. LTD, CHINA
About Your Workshop Leader About Your Workshop Leader
Dr. Jincai (Jimmy) Li is responsible for cell culture process development as well
as operation of the non-GMP pilot plant. He has extended experience in both
mammalian cell culture and microbial fermentation. His expertise includes
recombinant protein, especially monoclonal antibody expression and process
development, scale-up, technology transfer, process characterization and
validation, as well as post-marketing process improvement. Before joining
Wuxi, Dr. Li was Sr. Engineer and Group Leader at Genentech Inc., where he
led a group responsible for cell culture process development. He participated
in multiple monoclonal antibody therapeutic projectsí cell culture process
development, clinical material production, IND submission and also in several
Phase III as well as post-marketing products’ tech transfer and process
characterization/validation work. In addition, Dr. Li was also a core member
of the team that developed Genentech’s next-generation chemically-defined
cell culture medium and process platform, and his team developed the record
9+ g/L cell culture process at Genentech. Before Genentech, Dr. Li also worked
atTanox, Inc., where he led the manufacturing sciences group supporting PhIII
production of a mAb product, and at Diversa Corporation (now Verenium), in
charge of process development for multiple recombinant enzyme projects.
Dr. Li is the author of over a dozen peer-reviewed publications and patents.
Dr.Wheelwright has 30 years of hands on expertise quality assurance, regulatory,
manufacturing and process development. He has directly participated in
developing oncology, infectious disease, cardiovascular, wound healing,
angiogenesis, vaccine and diagnostic products. Dr. Wheelwright has been an
executive officer in several biotech startups, and has supervised the areas of
manufacturing, process development, compliance, quality assurance, quality
control, validation, engineering and facilities. He has led the development of
several products that are now on the market and has led the construction of
multiple manufacturing facilities that meet cGMP requirements. His corporate
experience includes Abbott, Chiron (now Novartis) and Scios (now J&J). Dr.
Wheelwright served as the founding COO for Innovent, a biopharmaceutical
company in China, and is founder and president of Strategic Manufacturing
Worldwide, Inc., a consulting firm that provides business and technical expertise
to biotech and related industries. Dr. Wheelwright obtained his PhD degree
in chemical engineering from the University of California at Berkeley and
performed post-doctoral studies in biophysics at the Max Planck Institute in
Germany. He is the author of a book on protein purification and has published
many papers on process design, manufacturing, and compliance for
pharmaceuticals and biologics.
PRE-CONFERENCE WORKSHOP: 20 MAY 2014
POST-CONFERENCE WORKSHOP: 23 MAY 2014

5. REGISTERTODAY! +65 6508 2401 / +86 21 2326 3680 register@ibcasia.com.sg www.biomanufacturing-asia.com
About the BDP Week
The Biopharma Development & Production Week is
the leading industry platform for pharma, biotech,
CMOs, CROs, research institutes, investors and industry
stakeholders to meet, network and discuss current
industry trends, establish business partnerships
and be updated on investment opportunities in
China and surrounding Asia.
Visit www.biopharmaproduction.com for more
information.
Co-Located with:
30+ Top Level Speakers
New Pre & Post Interactive Workshops
4 Interactive Panel Discussions
Hot Topic Round Table Discussions
Meet the Experts Via Specially Hosted VIP Lunch Tables
Speed Networking Sessions
Morning Ice Breaker & Get to Know your Peers
Conference Cocktail
Acceleron Pharma • AlphaMab • Amgen • Autekbio • Bayer HealthCare • Berna Biotech Korea • Biopharm Services • BioPharmaNeer Alliance • Bioprocessing
Technology Institute • Boehringer Ingelheim • Bristol-Myers Squibb • Celltrion Healthcare • Chugai Pharmaceutical • CMC Biologics • CMC Biologics •
Compliance Concepts International • Daewoong Pharmaceutical • DMS Biotechnology • Dow Corning • ExcellGene • Genor Biopharma • Genzyme/Sanofi •
Indian Immunologicals • Innobiologics • Innovent Biologics • Mass Biologics • Novasep • Pfizer Biotherapeutics • Sartorius Stedim Biotech • Saint Gobain •
SFDA Training Center • Shanghai Henlius Biotech • Swiss Federal Institute of Technology • Wuxi Apptec • Yooyoung Pharmaceutical & many more
20 — 23 May 2014
Grand Hyatt Shanghai, China
Part of
PRODUCTION
BIOPHARMA
DEVELOPMENT &
WEEK
Asian countries such as India, Singapore, South Korea
& China are fast becoming biomanufacturing hubs.
Biologics manufacturing is a huge investment & can
amount to US10 million or more to construct, equip, &
launch a successful certified GMP plant facility
(Biospectrum Asia, 2013). With the intensifying growth
& demand of biologics production, IBC’s 4th Annual
Biomanufacturing Conference provides a timely
platform to explore the opportunities & challenges
faced in this sector including:
The investment opportunities for entering the
biomanufacturing market in China & the surrounding
Asian region
Bridging the quality differences of China GMP
Standards vs. Europe & the US
What is the growth potential & opportunity for
disposable technologies in biomanufacturing in
China?
Identifying the critical factors in choosing the right
outsourcing partner
Developing a robust commercial process for
technology transfer
Examining the impact of the US H.R. 3204 Drug Quality
& Security Act in the biomanufacturing industry
For sponsorship opportunities, contact Yvonne Leong at
Tel: +65 6508 2489
Email: Yvonne.leong@ibcasia.com.sg
BY INDUSTRY
■ Biopharmaceutical / Pharmaceutical /
Biotechnology 45%
■ Technology and Solution Service Providers 20%
■ CMO 15%
■ Research Institutes 10%
■ Government 10%
www.biosimilarasia.com
www.celllineasia.com
LIMITED SPONSORSHIP & EXHIBITION OPPORTUNITIES AVAILABLE
Do you provide innovative technology to support the biomanufacturing Industry in Asia?
• Showcase the latest technology
• Meet & network with senior decision makers in Asia
• Position your brand as the market leader to stand out amidst
competition
• Generate new business contacts & strengthen existing accounts
Who Should Attend
SNAPSHOT OF PAST ATTENDING COMPANIES INCLUDE:
Abundant Networking Opportunities &
Interactive Formats!
AnInternationalEvent
China, Taiwan, Hong Kong 55%
Europe 10%
USA 5%
Australia 5%Southeast Asia 10%
Japan,
Korea 10%
India 5%

6. GROUP BONUS: REGISTER 3 DELEGATES FROM THE SAME COMPANY AND THE 4TH ATTENDS FOR FREE!
CREDIT CARD PAYMENTS
The best way to pay by credit card is through our secure on-line registration process, simply log on to the website at www.biomanufacturing-
asia.com and click “Register On-line”. If you would prefer to pay over the phone please complete the contact name and details and our
Customer Services Team will call within 24 hours to take payment. As we treat your credit card information in the strictest confidence, please
do not send payment details by email.
Credit card contact: Department:
Direct phone number: Email:
Grand Hyatt Shanghai, China
Jin Mao Tower, 88 Century Boulevard
Pudong, Shanghai 200121
Tel: +86 21 5049 1234 | Fax: +86 21 5049 8381
Contact Person: Judy Xu
Email: judy.xu@hyatt.com
ENJOY SUBSTANTIAL SAVINGS WITH
OUR MULTIPLE BOOKING DISCOUNT!
Early Bird Rate
Register & pay on or
before 14 Mar 2014
FEE PER DELEGATE Special Rate
Register & pay before
11 Apr 2014
Group Rate
(3 or more delegates)
Normal Rate
Register & pay after
11 Apr 2014
111 Somerset Road,
TripleOne Somerset #10-06, Singapore 238164
Tel: +65 6508 2400 Fax: +65 6508 2408
REGISTER NOW! FAX BACK TO +65 6508 2407
HOTEL INFORMATION
DATA PROTECTION
PAYMENT TERMS
CANCELLATION / SUBSTITUTION
IMPORTANT NOTE
This label contains your priority booking code. To expedite registration, please do not remove label. If you have
already received a copy of this brochure, we apologise. For reasons of confidentiality, your full particulars were not
available to IBC Asia (S) Pte Ltd for deduplication prior to mail drop.
6 EASY WAYS TO REGISTER
REGNO.200108203N
4th Annual BioManuacturing
RESERVE YOUR PLACE TODAY!
P46238
USD 2,695 USD 2,895 USD 2,995 USD 2,495
If undelivered, please return to:
MAIL the attached registration form with
your cheque to IBC Asia (S) Pte Ltd
c/o Informa Regional Business
Services
111 Somerset Road, TripleOne
Somerset #10-06, Singapore 238164
Email
register@ibcasia.com.sg
Fax
+65 6508 2407
Web
www.biomanufacturing-asia.com
SAVE WITH THE
EARLY BIRD &
SPECIAL RATES!
Scan the QR Code
with your smartphone
and register today
The personal information entered during your registration/order, or
provided by you, will be held on a database and may be shared
with companies in the Informa Group in the UK and internationally.
Occasionally, your details may be obtained from or shared with
external companies who wish to communicate with you offers
related to your business activities. If you do not wish your details
to be used for this purpose, please contact our Database Department
at Email: database@ibcasia.com.sg, Tel: +65 6508 2400 or
Fax: +65 6508 2408.
Should you be unable to attend, a substitute delegate is welcome
at no extra charge. Cancellations must be received in writing at
least 10 business days before the start of the event, to receive a
refund less 10% processing fee per registration. The company
regrets that no refund will be made available for cancellation
notifications received less than 10 business days before the event.
Please quote the name of the delegate, event title and invoice
number on the advice when remitting payment. Bank charges are
to be deducted from participating organisations own accounts.
Please fax your payment details (copy of remittance advice, cheque
or draft to +65 6508 2407).
Attendance will only be permitted upon receipt of full payment.
Participants wishing to register at the door are responsible to ensure
all details are as published. IBC assumes no further liability or
obligation, beyond the refund of the paid registration fee, in the
event of postponement or cancellation by IBC.
❑ Yes! I/We will attend the 4th Annual BioManufacturing
20 – 23 May 2014, Grand Hyatt Shanghai, China
❑ I would like to purchase the conference presentations
at SGD1000 + GST (SGD1070) per log in.
Payment must be received 10 business days prior to the event.
To take advantage of discounts with an expiry cut-off date,
registration and payment must be received by the cut-off date.
All payments should be made in US or CNY dollars.
• Payments by US$ bank draft or cheque should be made in
favour of “IBC Asia (S) Pte Ltd” and mailed to:
IBC Asia (S) Pte Ltd
c/o Informa Regional Business Services
111 Somerset Road, TripleOne Somerset #10-06,
Singapore 238164
Attn: The Accounts Receivable Team
• Payment by telegraphic transfer in US$ must be made to:
IBC Asia (S) Pte Ltd
A/C No.: 260-457866-178 (USD)
The Hongkong and Shanghai Banking Corporation Limited,
21 Collyer Quay, HSBC Building, Singapore 049320
Bank Swift Code: HSBCSGSG
Bank Code: 7232
• Payment by telegraphic transfer in CNY must be made to:
A/C Name:
Conferences and Event Management Services (Shanghai)
Co., Ltd.
A/C No.: 720-031103-001
Beneficiary Bank:
Bank (China) Company Limited
Bank Address: No. 1000 Lujiazui Rind Road, Pudong, Shanghai
200120, P.R. China
• Payment by credit card in US$ (AMEX, VISA or MasterCard)
The best way to pay by credit card is through our secure portal
built into the website. To pay by phone please indicate the
contact name and details below and our Customer Services
Team will call within 24 hours to take payment. Please do not
send credit card information by email.
HSBC
IBC
USD 2,295 USD 2,495 USD 2,595 USD 2,095
International Companies
USD 1,695 USD 1,895 USD 1,995 USD 1,495
China Domestic Companies
CNY 6,500 CNY 7,500 CNY 8,000 CNY 6,000
CNY 5,500 CNY 6,500 CNY 7,000 CNY 5,000
CNY 4,500 CNY 5,500 CNY 6,000 CNY 4,000
Who is Head of your Department?
Who is Head of Training?
Company Information
Company Name:
Address:
Main Business/Activity:
Postal Code:
Please photocopy for additional delegates
FREE
GROUP DISCOUNT
Delegate 1 Details
Name: Dr/Mr/Ms
Job Title:
Department
Tel:
Mobile No.:
Email:
Delegate 2 Details
Name: Dr/Mr/Ms
Job Title:
Department
Tel:
Mobile No.:
Email:
Delegate 3 Details
Name: Dr/Mr/Ms
Job Title:
Department
Tel:
Mobile No.:
Email:
Delegate 4 Details
Name: Dr/Mr/Ms
Job Title:
Department
Tel:
Mobile No.:
Email:
• Multiple Bookings Discount pricing is applicable to groups of 3 or more delegates from the same organisation registering for the same event, at the same time. Fee stated
is the discounted price PER DELEGATE. Only one discount applies; either the early bird rate OR special rate OR group rate.
• All fees stated include luncheons, refreshments and complete set of documentation. It does not include the cost of accommodation and travel.
• Registration fees are subject to the prevailing government tax
International companies have Global Headquarters located outside mainland China. A China domestic company has its global headquarters located
within mainland China. Regulatory Authorities, Government and Academia will be accorded 40% off Normal Rates
Payment Method (Please tick:) ❑ I enclose my bankers draft / cheque payable to IBC Asia (S) Pte Ltd
❑ I am paying by bank transfer (copy attached)
❑ Payment by Credit Card. (AMEX, VISA or MasterCard accepted)
Customer Service Hotline
+65 6508 2401 [Singapore]
+86 21 2326 3680 [China]
❑ 2 Day Package - 2 Day Conference only
❑ 4 Day Package - 2 Day Conference +
Pre & Post Workshops
❑ 3 Day Package - 2 Day Conference +
❑ Pre OR ❑ Post Workshop
❑ 2 Day Package - 2 Day Conference only
❑ 4 Day Package - 2 Day Conference +
Pre & Post Workshops
❑ 3 Day Package - 2 Day Conference +
❑ Pre OR ❑ Post Workshop